Reuters logo
BRIEF-Teva announces submission of biologics license application for Fremanezumab to U.S. FDA
2017年10月17日 / 中午12点23分 / 1 个月前

BRIEF-Teva announces submission of biologics license application for Fremanezumab to U.S. FDA

Oct 17 (Reuters) - Teva Pharmaceutical Industries Ltd

* Teva announces submission of biologics license application for Fremanezumab to the U.S. FDA

* Teva Pharmaceutical Industries Ltd - ‍submission of a biologics license application to U.S. FDA for Fremanezumab​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below